Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TPMT | P51580 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22570608 | 1.00 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL22570518 | 1.00 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL22570607 | 1.00 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL22570613 | 1.00 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL901207 | 0.81 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL901209 | 0.81 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL2321634 | 0.81 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL20656934 | 0.80 | MAOA (0.60) | — | |
| SCHEMBL20897633 | 0.80 | TSHR (0.52) | TSHRTP53SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL20897834 | 0.80 | TSHR (0.52) | TSHRTP53SRD5A2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961178-B2 | Cycloaddition reactions using quantum dots | NORTHWESTERN UNIVERSITY (US) | 2021-03-30 | — | — | US | disclosed |
| US-20200331836-A1 | CYCLOADDITION REACTIONS USING QUANTUM DOTS | NORTHWESTERN UNIVERSITY | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331836-A1 | CYCLOADDITION REACTIONS USING QUANTUM DOTS | SYNGR2, SYNJ1, SQLE | TSHR 3658/4885TP53 3389/4885SRD5A2 3287/4885 |
| US-10961178-B2 | Cycloaddition reactions using quantum dots | SYNGR2, SYNJ1, SQLE | TSHR 3658/4885TP53 3389/4885SRD5A2 3287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.